Aadi Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Aadi Bioscience's estimated annual revenue is currently $16.6M per year.
- Aadi Bioscience's estimated revenue per employee is $155,000
Employee Data
- Aadi Bioscience has 107 Employees.
- Aadi Bioscience grew their employee count by 26% last year.
Aadi Bioscience's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & Executive Chairman | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
3 | Interim CFO | Reveal Email/Phone |
4 | SVP and General Counsel | Reveal Email/Phone |
5 | CQO and SVP Manufacturing Operations | Reveal Email/Phone |
6 | Sr VP RA/QA | Reveal Email/Phone |
7 | VP, BD & Corporate Strategy | Reveal Email/Phone |
Aadi Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Aadi Bioscience?
Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers. We strive to unleash the potential of mTOR inhibition by employing precision medicine & nanoparticle technology to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Our lead product has been FDA-approved for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa). Our world class leadership team is comprised of industry veterans from top biotech companies who have proven track records of bringing novel cancer therapies to market. A science-first mindset and patient-centric approach is in our genes. With a growing pipeline of studies, we remain dedicated to developing products for cancers with mTOR pathway driver alterations. For more information, please visit: https://aadibio.com/
keywords:N/AN/A
Total Funding
107
Number of Employees
$16.6M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 107 | 1% | N/A |
#2 | $15.5M | 107 | 7% | N/A |
#3 | $31M | 107 | -7% | N/A |
#4 | $18.6M | 107 | -4% | N/A |
#5 | $15M | 107 | -5% | N/A |